ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05217	Basal cell carcinoma	24/335	68/7206	1.07473824634e-15
ko04550	Signaling pathways regulating pluripotency of stem cells	33/335	165/7206	4.86226269039e-13
ko04360	Axon guidance	37/335	233/7206	2.65738906904e-11
ko05224	Breast cancer	31/335	174/7206	6.04600894493e-11
ko04340	Hedgehog signaling pathway	17/335	58/7206	5.12719388935e-10
ko04950	Maturity onset diabetes of the young	11/335	29/7206	3.03489470558e-08
ko05200	Pathways in cancer	51/335	492/7206	4.12653085512e-08
ko05202	Transcriptional misregulation in cancer	26/335	188/7206	4.79040284958e-07
ko04330	Notch signaling pathway	14/335	62/7206	6.41374580702e-07
ko04310	Wnt signaling pathway	25/335	181/7206	8.2144939223e-07
ko04390	Hippo signaling pathway	25/335	188/7206	1.68313836754e-06
ko04512	ECM-receptor interaction	15/335	79/7206	2.67928859871e-06
ko04080	Neuroactive ligand-receptor interaction	5/335	423/7206	0.000108413334499
ko04974	Protein digestion and absorption	13/335	96/7206	0.000459070329584
ko04916	Melanogenesis	16/335	142/7206	0.00086331300831
ko04391	Hippo signaling pathway - fly	12/335	90/7206	0.00086915228434
ko00230	Purine metabolism	1/335	194/7206	0.00157058462657
ko04072	Phospholipase D signaling pathway	1/335	197/7206	0.00159670220845
ko04932	Non-alcoholic fatty liver disease (NAFLD)	1/335	182/7206	0.00348365626314
ko04510	Focal adhesion	21/335	240/7206	0.0045530241949
ko04723	Retrograde endocannabinoid signaling	1/335	175/7206	0.00519480301883
ko00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	5/335	26/7206	0.00618324602276
ko05010	Alzheimer's disease	2/335	202/7206	0.00620210185879
ko04921	Oxytocin signaling pathway	2/335	209/7206	0.00652859473419
ko04611	Platelet activation	1/335	163/7206	0.00720077269233
ko04341	Hedgehog signaling pathway - fly	6/335	38/7206	0.00755512821089
ko05222	Small cell lung cancer	10/335	89/7206	0.00798640251315
ko05206	MicroRNAs in cancer	16/335	177/7206	0.00998080103778
ko04020	Calcium signaling pathway	4/335	265/7206	0.0104532477123
ko05012	Parkinson's disease	1/335	155/7206	0.0105034445686
ko05205	Proteoglycans in cancer	22/335	271/7206	0.0112554626713
ko00514	Other types of O-glycan biosynthesis	5/335	30/7206	0.011509572212
ko04141	Protein processing in endoplasmic reticulum	2/335	184/7206	0.0124616074558
ko05166	HTLV-I infection	23/335	292/7206	0.0146084870938
ko04371	Apelin signaling pathway	2/335	177/7206	0.0176328761762
ko04151	PI3K-Akt signaling pathway	28/335	390/7206	0.0186539429384
ko05203	Viral carcinogenesis	5/335	277/7206	0.0187887506375
ko00310	Lysine degradation	8/335	73/7206	0.0193873623345
ko04514	Cell adhesion molecules (CAMs)	12/335	130/7206	0.0194068643014
ko04919	Thyroid hormone signaling pathway	13/335	143/7206	0.0237576420889
ko04062	Chemokine signaling pathway	3/335	201/7206	0.0260151074872
ko05034	Alcoholism	4/335	238/7206	0.0265246316703
ko03410	Base excision repair	5/335	38/7206	0.0300015986883
ko00190	Oxidative phosphorylation	1/335	127/7206	0.0311242888745
ko05142	Chagas disease (American trypanosomiasis)	1/335	130/7206	0.0319265629011
ko04144	Endocytosis	8/335	342/7206	0.0347457393932
ko04071	Sphingolipid signaling pathway	2/335	162/7206	0.0352669270633
ko04140	Autophagy - animal	2/335	164/7206	0.0358821908624
ko04912	GnRH signaling pathway	1/335	122/7206	0.0462372969685
ko04750	Inflammatory mediator regulation of TRP channels	1/335	122/7206	0.0462372969685
ko04022	cGMP-PKG signaling pathway	4/335	216/7206	0.0473850119674
ko05322	Systemic lupus erythematosus	2/335	151/7206	0.0487046686579